Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-05-003427
Filing Date
2005-02-14
Accepted
2005-02-14 20:00:34
Documents
1
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 - edgar.html 5  
1 FORM 5 - edgar.xml 5 4999
  Complete submission text file 0001179110-05-003427.txt   6739
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES INC (Issuer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address SOCIETE GENERALE DE BELGIQUE RUE ROYALE 30 BRUSSELS C9 000000
Business Address
DAVIGNON ETIENNE (Reporting) CIK: 0001198226 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-19731 | Film No.: 05614120